Praxis Precision Medicines, Inc. Common Stock (PRAX) Financials
Key financial figures for Praxis Precision Medicines, Inc. Common Stock (Q2 2026).
- Revenue
- $0
- Net Income
- -$84M
- EPS
- $-2.87
- Total Assets
- $1.4B
- Operating Cash Flow
- -$78M
Full income statement, balance sheet, and cash flow for Praxis Precision Medicines, Inc. Common Stock on SentiSense.